Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Gang Liu, Ping Men & Gerry H. Kenner. (2011) 1-(2-Hydroxyethoxy)Methyl-2-Methyl-3-Hydroxyl-4-Pyridinone: ATargeted, Bifunctional Chelating Agent for Potential Uranic Detoxification in the Kidney. Hemoglobin 35:3, pages 291-300.
Read now
Read now
Raymond J. Bergeron, Jan Wiegand & Shailendra Singh. (2009) Desferrithiocin analogue uranium decorporation agents. International Journal of Radiation Biology 85:4, pages 348-361.
Read now
Read now
Satoshi Fukuda, Mizuyo Ikeda, Mariko Nakamura, Akira Katoh, Xueming Yan, Yuyuan Xie & George J. Kontoghiorghes. (2008) The Effects of Bicarbonate and its Combination with Chelating Agents Used for the Removal of Depleted Uranium in Rats. Hemoglobin 32:1-2, pages 191-198.
Read now
Read now
Articles from other publishers (36)
Joshua J. Woods, Ryan Unnerstall, Abbie Hasson, Diane S. Abou, Valery Radchenko, Daniel L. J. Thorek & Justin J. Wilson. (2022)
Stable Chelation of the Uranyl Ion by Acyclic Hexadentate Ligands: Potential Applications for
230
U Targeted α-Therapy
. Inorganic Chemistry 61:7, pages 3337-3350.
Crossref
Crossref
Larry S. Keith & Obaid M. Faroon. 2022. Handbook on the Toxicology of Metals. Handbook on the Toxicology of Metals
885
936
.
Aditya Garai & Pascale Delangle. (2020) Recent advances in uranyl binding in proteins thanks to biomimetic peptides. Journal of Inorganic Biochemistry 203, pages 110936.
Crossref
Crossref
Fanny A. Laporte, Colette Lebrun, Claude Vidaud & Pascale Delangle. (2019) Phosphate‐Rich Biomimetic Peptides Shed Light on High‐Affinity Hyperphosphorylated Uranyl Binding Sites in Phosphoproteins. Chemistry – A European Journal 25:36, pages 8570-8578.
Crossref
Crossref
Xiaomei Wang, Xing Dai, Cen Shi, Jianmei Wan, Mark A. Silver, Linjuan Zhang, Lanhua Chen, Xuan Yi, Bizheng Chen, Duo Zhang, Kai Yang, Juan Diwu, Jianqiang Wang, Yujie Xu, Ruhong Zhou, Zhifang Chai & Shuao Wang. (2019) A 3,2-Hydroxypyridinone-based Decorporation Agent that Removes Uranium from Bones In Vivo. Nature Communications 10:1.
Crossref
Crossref
Manohar Mahato, Nicholas E. Sherman, N. Kiran Kumar Mudnakudu, Nitin Joshi, Elisabeth Briand, Jeffrey M. Karp & Praveen Kumar Vemula. 2018. Metal Allergy. Metal Allergy
227
246
.
Ole Andersen. 2016. Chelation Therapy in the Treatment of Metal Intoxication. Chelation Therapy in the Treatment of Metal Intoxication
253
284
.
Elias Fattal, Nicolas Tsapis & Guillaume Phan. (2015) Novel drug delivery systems for actinides (uranium and plutonium) decontamination agents. Advanced Drug Delivery Reviews 90, pages 40-54.
Crossref
Crossref
Yubo Shu, Zhenghua Ju, Hongrui Zhang & Weisheng Liu. (2014) Complexation of uranyl ions by N-(sulfoethyl)-iminodiacetic acid: Hydrothermal synthesis, luminescence, and uranyl sequestration. Science China Chemistry 58:5, pages 845-849.
Crossref
Crossref
Yasushi Ohmachi, Tomomi Imamura, Mizuyo Ikeda, Eriko Shishikura, Eunjoo Kim, Osamu Kurihara & Kazuo Sakai. (2015) Sodium bicarbonate protects uranium-induced acute nephrotoxicity through uranium-decorporation by urinary alkalinization in rats. Journal of Toxicologic Pathology 28:2, pages 65-71.
Crossref
Crossref
Larry S. Keith, Obaid M. Faroon & Bruce A. Fowler. 2015. Handbook on the Toxicology of Metals. Handbook on the Toxicology of Metals
1307
1345
.
Martin Mkandawire. (2013) Biogeochemical behaviour and bioremediation of uranium in waters of abandoned mines. Environmental Science and Pollution Research 20:11, pages 7740-7767.
Crossref
Crossref
Yizhong Bao, Dan Wang, Yuxing Hu, Aihong Xu & Honghong Chen. (2013) Efficacy of Chelator CBMIDA-CaNa2 for the Removal of Uranium and Protection against Uranium-induced Cell Damage in Human Renal Proximal Tubular Cells. Health Physics 105:1, pages 31-38.
Crossref
Crossref
Yizhong Bao, Dan Wang, Zhiming Li, Yuxing Hu, Aihong Xu, Quanrui Wang, Chunlin Shao & Honghong Chen. (2013) Efficacy of a novel chelator BPCBG for removing uranium and protecting against uranium-induced renal cell damage in rats and HK-2 cells. Toxicology and Applied Pharmacology 269:1, pages 17-24.
Crossref
Crossref
Laura Vicente-Vicente, Yaremi Quiros, Fernando Pérez-Barriocanal, José Miguel López-Novoa, Francisco José López-Hernández & Ana Isabel Morales. (2010) Nephrotoxicity of Uranium: Pathophysiological, Diagnostic and Therapeutic Perspectives. Toxicological Sciences 118:2, pages 324-347.
Crossref
Crossref
Satoshi Fukuda, Mizuyo Ikeda, Mariko Nakamura, Xueming Yan & Yuyuan Xie. (2009) ACUTE TOXICITY OF SUBCUTANEOUSLY ADMINISTERED DEPLETED URANIUM AND THE EFFECTS OF CBMIDA IN THE SIMULATED WOUNDS OF RATS. Health Physics 96:4, pages 483-492.
Crossref
Crossref
S. Fukuda, M. Ikeda, M. Nakamura, X. Yan & Y. Xie. (2009) Efficacy of oral and intraperitoneal administration of CBMIDA for removing uranium in rats after parenteral injections of depleted uranium. Radiation Protection Dosimetry 133:1, pages 12-19.
Crossref
Crossref
Patricia W. Durbin. (2008) LAURISTON S. TAYLOR LECTURE: THE QUEST FOR THERAPEUTIC ACTINIDE CHELATORS. Health Physics 95:5, pages 465-492.
Crossref
Crossref
Montserrat Bellés, Victoria Linares, M. Luisa Albina, Joan Sirvent, Domènec J. Sánchez & José L. Domingo. (2007) Melatonin reduces uranium-induced nephrotoxicity in rats. Journal of Pineal Research 43:1, pages 87-95.
Crossref
Crossref
Satoshi Fukuda, Mizuyo Ikeda, Mariko Nakamura, Xueming Yan & Yuyuan Xie. (2007) EFFECTS OF pH ON DU INTAKE AND REMOVAL BY CBMIDA AND EHBP. Health Physics 92:1, pages 10-14.
Crossref
Crossref
B. B. Tewari. (2006) Electrophoretic studies on the mixed nitrilotriacetate-penicillamine complexes of Pb2+ and UO2+2. Russian Journal of Inorganic Chemistry 51:3, pages 499-503.
Crossref
Crossref
C. B. Bozal, A. B. Martinez, R. L. Cabrini & A. M. Ubios. (2005) Effect of ethane-1-hydroxy-1,1-bisphosphonate (EHBP) on endochondral ossification lesions induced by a lethal oral dose of uranyl nitrate. Archives of Toxicology 79:8, pages 475-481.
Crossref
Crossref
Satoshi Fukuda, Haruzo Iida, Mizuyo Ikeda, Xueming Yan & Yuyuan Xie. (2005) TOXICITY OF URANIUM AND THE REMOVAL EFFECTS OF CBMIDA AND EHBP IN SIMULATED WOUNDS OF RATS. Health Physics 89:1, pages 81-88.
Crossref
Crossref
Marcin Sawicki, Jean‐Michel Siaugue, Christophe Jacopin, Christophe Moulin, Théodorine Bailly, Ramon Burgada, Stéphane Meunier, Paul Baret, Jean‐Louis Pierre & Frédéric Taran. (2005) Discovery of Powerful Uranyl Ligands from Efficient Synthesis and Screening. Chemistry – A European Journal 11:12, pages 3689-3697.
Crossref
Crossref
B. B. Tewari. (2005) Studies on the Interaction of Lead(II) and Uranyl(II) with Methylcysteine and Penicillamine Bioactive Sulfur-Containing Ligands. Russian Journal of Coordination Chemistry 31:5, pages 322-326.
Crossref
Crossref
G. N. Stradling & D. M. Taylor. 2005. Radiological Protection. Radiological Protection
295
328
.
Ramon Burgada, Theodorine Bailly & Marc Lecouvey. (2004) Synthèse de ligands bisphosphoniques pour la complexation de l’ion uranyle du cobalt et du fer. Comptes Rendus Chimie 7:1, pages 35-39.
Crossref
Crossref
Anne E. V. Gorden, Jide Xu, Kenneth N. Raymond & Patricia Durbin. (2003) Rational Design of Sequestering Agents for Plutonium and Other Actinides. Chemical Reviews 103:11, pages 4207-4282.
Crossref
Crossref
A. B. Martinez, P. M. Mandalunis, C. B. Bozal, R. L. Cabrini & A. M. Ubios. (2003) RENAL FUNCTION IN MICE POISONED WITH ORAL URANIUM AND TREATED WITH ETHANE-1-HYDROXY-1,1-BISPHOSPHONATE (EHBP). Health Physics 85:3, pages 343-347.
Crossref
Crossref
Christophe Jacopin, Marcin Sawicki, Gabriel Plancque, Denis Doizi, Frédéric Taran, Eric Ansoborlo, Badia Amekraz & Christophe Moulin. (2003) Investigation of the Interaction between 1-Hydroxyethane-1,1‘-diphosphonic Acid (HEDP) and Uranium(VI). Inorganic Chemistry 42:16, pages 5015-5022.
Crossref
Crossref
Jose L. Domingo. (2001) Reproductive and developmental toxicity of natural and depleted uranium: a review. Reproductive Toxicology 15:6, pages 603-609.
Crossref
Crossref
R. Burgada, T. Bailly, J. P. Noël, J. M. Gomis, A. Valleix, E. Ansoborlo, M. H. Hengé‐Napoli, F. Paquet & P. Gourmelon. (2001)
Synthesis of 3,4,3 LI 1,2 HOPO labelled with
14
C
. Journal of Labelled Compounds and Radiopharmaceuticals 44:1, pages 13-19.
Crossref
Crossref
Ramon Burgada, Theodorine Bailly, Marc Lecouvey, Valery Larue & Yves Leroux. (2001) Synthesis of New Phosphonated Tripod Ligands as Putative New Therapeutic Agents in the Chelation Treatment of Metal Intoxications. European Journal of Organic Chemistry 2001:2, pages 349-352.
Crossref
Crossref
Patricia W. Durbin, Birgitta Kullgren, Shirley N. Ebbe, Jide Xu & Kenneth N. Raymond. (2000) CHELATING AGENTS FOR URANIUM(VI): 2. EFFICACY AND TOXICITY OF TETRADENTATE CATECHOLATE AND HYDROXYPYRIDINONATE LIGANDS IN MICE. Health Physics 78:5, pages 511-521.
Crossref
Crossref
G.N Stradling. (1998) Decorporation of actinides: a review of recent research. Journal of Alloys and Compounds 271-273, pages 72-77.
Crossref
Crossref
Théodorine Bailly & Ramon Burgada. (1998) Nouvelle méthode de synthèse du 3,4,3 LI 1,2 HOPO (1,5,10,14-tétra (1-hydroxy-2-pyridone-6 oyl) 1,5,10,14 tétraazatétradécane). Comptes Rendus de l'Académie des Sciences - Series IIC - Chemistry 1:4, pages 241-245.
Crossref
Crossref